Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2007
06/26/2007US7235247 Aqueous solution; efficient penetration
06/26/2007CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them
06/26/2007CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
06/26/2007CA2197176C Use of selegiline for the treatment of epileptic disorders
06/26/2007CA2185037C Iridaceae extract and compositions containing the same
06/22/2007CA2571276A1 Modified release formulation of lithium carbonate and method for the preparation thereof
06/21/2007WO2007070872A1 Kinase inhibitors and their uses
06/21/2007WO2007070504A2 Stable and palatable oral liquid sumatriptan compositions
06/21/2007WO2007070362A1 Indolone compounds useful to treat cognitive impairment
06/21/2007WO2007069977A1 Alkylsulphonamide quinolines
06/21/2007WO2007069773A1 A pharmaceutical composition comprising an amide derivative
06/21/2007WO2007069712A1 Amine compound and use thereof for medical purposes
06/21/2007WO2007069671A1 Bicyclic heterocyclic compound
06/21/2007WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007069603A1 Physiologically active glycolipid
06/21/2007WO2007069565A1 Bicyclic heterocyclic compound
06/21/2007WO2007068983A1 New treatment
06/21/2007WO2007068829A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine
06/21/2007WO2007068803A1 Novel neurotrophic factor protein and uses thereof
06/21/2007WO2007068754A1 Dibenzene derivatives as calcium channel blockers
06/21/2007WO2007068739A1 4-amino-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, neurological and cardiovascular disorders
06/21/2007WO2007068476A1 [ (1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders.
06/21/2007WO2007068475A1 (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(ih-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
06/21/2007WO2007068434A2 Medicament based on a monoester of steroids with long chain fatty acids
06/21/2007WO2007068429A1 Antibodies against amyloid beta 4 with glycosylated in the variable region
06/21/2007WO2007068418A1 Use of pyrrolo [2 , 3-b] pyridines to prepare a medicament for treating pain
06/21/2007WO2007068411A2 Therapeutic vaccine
06/21/2007WO2007068212A1 Intravenous emulsion of butylbenzene phthalein and its application
06/21/2007WO2007050697A3 Compositions and methods for the administration psychotropic drugs which modulate body weight
06/21/2007WO2007050353A3 Tricyclic compounds useful as oxytocin receptor agonists
06/21/2007WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders
06/21/2007WO2007042544A3 Imidazole derivatives and their use for modulating the gabaa receptor complex
06/21/2007WO2007009801A3 Oral, quickly disintegrating film, which cannot be spit out, for a neuroleptic drug
06/21/2007WO2006123257A8 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors
06/21/2007WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma
06/21/2007US20070142647 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142465 Macrophage activation inhibitor
06/21/2007US20070142431 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists
06/21/2007US20070142428 isoquinoline-3-carboxylic acid{(S)-1-azabicyclo[2.2.2]oct-3-yl}-amide; alpha 7 nicotinic acetylcholine receptor agonists; psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerative disorders such as senile dementia, Alzheimer's disease; attention deficit disorders
06/21/2007US20070142419 Thienyl Compounds
06/21/2007US20070142407 Benzo (1,2,5) thiadiazole als crf-antagonisten
06/21/2007US20070142400 Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
06/21/2007US20070142398 Tetracyclic 3-substituted indoles having serotonin receptor affinity
06/21/2007US20070142386 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142366 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation
06/21/2007US20070142364 Flumazenil for the Treatment of Cocaine Dependency
06/21/2007US20070142357 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
06/21/2007US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
06/21/2007US20070142342 Pharmaceutical compounds
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142297 New uses for amino acid anticonvulsants
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142291 Methods for treating irritable bowel syndrome
06/21/2007US20070142266 Combination comprising a P-gp inhibitor and an anti-epileptic drug
06/21/2007US20070141173 Medicament comprising noble metal fine particles
06/21/2007US20070140975 Opioid formulations having reduced potential for abuse
06/21/2007US20070138897 Dc motor
06/21/2007DE102005060377A1 Composition, useful for preparing compressed form, preferably tablets to treat senile dementia, preferably for preventing and alleviating Alzheimer's disease, comprises donepezil hydrochloride of polymorph form
06/21/2007CA2634004A1 Dibenzene derivatives as calcium channel blockers
06/21/2007CA2633829A1 Indolone compounds useful to treat cognitive impairment
06/21/2007CA2633501A1 Immunoglobulins directed against nogo
06/21/2007CA2633399A1 Therapeutic vaccine
06/21/2007CA2633374A1 Amine compound and use thereof for medical purposes
06/21/2007CA2633129A1 Alkylsulphonamide quinolines
06/21/2007CA2633093A1 Mglur1 antagonists as therapeutic agents
06/21/2007CA2633035A1 Kinase inhibitors and their uses
06/21/2007CA2632893A1 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
06/21/2007CA2632822A1 A beta 1-42 specific monoclonal antibodies with therapeutic properties
06/21/2007CA2632550A1 Medium chain triglycerides for preserving cognitive function
06/21/2007CA2631654A1 [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders
06/21/2007CA2629778A1 Use of pyrrolo [2 , 3-b] pyridines to prepare a medicament for treating pain
06/21/2007CA2611586A1 Pharmaceutical formulations of amyloid inhibiting compounds
06/20/2007EP1798285A1 Methods and medicament for inhibition the expression of a defined gene
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound
06/20/2007EP1798220A1 Dibenzene derivatives as calcium channel blockers
06/20/2007EP1797890A1 A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof
06/20/2007EP1797878A2 Benzothiazole derivatives
06/20/2007EP1797875A2 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
06/20/2007EP1797871A1 Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof
06/20/2007EP1797869A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
06/20/2007EP1797171A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs)
06/20/2007EP1797104A1 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and method of making them
06/20/2007EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists
06/20/2007EP1797088A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/20/2007EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS
06/20/2007EP1797078A1 Compounds, compositions containing them, preparation thereof and uses thereof iii
06/20/2007EP1797077A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
06/20/2007EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/20/2007EP1797075A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands
06/20/2007EP1797074A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii
1 ... 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 ... 1833